Western Pacific
Diabetes regional report 2000 — 2050
Number of adults (20–79 years) with diabetes in Western Pacific (WP)
| 2000 | 44.1 million |
| 2011 | 131.9 million |
| 2024 | 215.4 million |
| 2050 | 253.8 million |
Estimates are included for 37 countries and territories in the IDF Western Pacific (WP) Region. A total of 40 data sources from 28 countries were used to generate estimates of diabetes in adults aged 20–79 years. Estimates for Australia, Vietnam, Republic of Korea, Singapore, Malaysia and Mongolia were based on studies conducted within the past five years.
The WP Region accounts for over a third (37%) of the total number of adults living with diabetes, and has the third highest diabetes prevalence (12.4%) of all IDF Regions. IDF projects that the number of people with diabetes in the WP Region will increase by 18%, reaching 254 million by 2050, and that the prevalence of diabetes will increase by 19% to reach 14.7% in 2050. The proportion of undiagnosed diabetes (50%) is the second highest of all IDF Regions. Diabetes is responsible for 1.2 million deaths in 2024, the highest number of all IDF Regions. Diabetes-related expenditure in 2024 totals USD 246 billion, the second highest of all IDF Regions and representing 24% of global expenditure.
| Diabetes estimates (20-79 y) | ||||
|---|---|---|---|---|
| People with diabetes, in 1,000s | 44,097.9 | 131,895.1 | 215,440.7 | 253,810.0 |
| Age-standardised prevalence of diabetes, % | 3.6 | 8.3 | 11.1 | 12.8 |
| Proportion of people with undiagnosed diabetes, % | - | - | 50.0 | - |
| People with undiagnosed diabetes, in 1,000s | - | - | 107,619.2 | - |
| Impaired Fasting Glucose (IFG) | ||||
|---|---|---|---|---|
| People with IFG, in 1,000s | - | - | 159,547.2 | 171,131.7 |
| Age-standardised prevalence of IFG, % | - | - | 8.6 | 9.2 |
| Impaired Glucose Tolerance (IGT) | ||||
|---|---|---|---|---|
| People with IGT, in 1,000s | - | 84,900.0 | 251,297.2 | 267,779.3 |
| Age-standardised prevalence of IGT, % | - | 5.4 | 13.5 | 14.3 |
| Mortality attributable to diabetes (20-79 y) | ||||
|---|---|---|---|---|
| Deaths attributable to diabetes | - | 1,708,300.0 | 1,198,360.6 | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 10.1 | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
|---|---|---|---|---|
| Live births affected by HIP | - | - | 4,177,968.8 | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | 17.5 | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | 382,594.5 | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | 286,134.6 | - |
| Diabetes-related health expenditure | ||||
|---|---|---|---|---|
| Total diabetes-related health expenditure, USD million | - | 72,200.0 | 246,342.9 | 237,699.8 |
| Total diabetes-related health expenditure, ID million | - | - | 436,860.9 | 431,805.4 |
| Diabetes-related health expenditure per person, USD | - | 1,169.9 | 1,173.5 | 960.7 |
| Diabetes-related health expenditure per person, ID | - | - | 2,081.1 | 1,745.3 |
| Type 1 diabetes estimates in children and adolescents | ||||
|---|---|---|---|---|
| People with type 1 diabetes (all age groups) | - | - | 990,990.0 | - |
| People with type 1 diabetes (0-19 y) | - | - | 181,376.0 | - |
| Demographics | ||||
|---|---|---|---|---|
| Total adult population (20-79 y), in 1,000s | 1,219,457.0 | 1,544,000.0 | 1,743,828.1 | 1,724,153.9 |
| Population of children and adolescents (0-19 y) | - | - | 586,687,935.0 | - |
| Diabetes estimates (20-79 y) | |
|---|---|
| People with diabetes, in 1,000s | 44,097.9 |
| Age-standardised prevalence of diabetes, % | 3.6 |
| Proportion of people with undiagnosed diabetes, % | - |
| People with undiagnosed diabetes, in 1,000s | - |
| Impaired Fasting Glucose (IFG) | |
|---|---|
| People with IFG, in 1,000s | - |
| Age-standardised prevalence of IFG, % | - |
| Impaired Glucose Tolerance (IGT) | |
|---|---|
| People with IGT, in 1,000s | - |
| Age-standardised prevalence of IGT, % | - |
| Mortality attributable to diabetes (20-79 y) | |
|---|---|
| Deaths attributable to diabetes | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
|---|---|
| Live births affected by HIP | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - |
| Live births affected by other types of diabetes first detected in pregnancy | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - |
| Diabetes-related health expenditure | |
|---|---|
| Total diabetes-related health expenditure, USD million | - |
| Total diabetes-related health expenditure, ID million | - |
| Diabetes-related health expenditure per person, USD | - |
| Diabetes-related health expenditure per person, ID | - |
| Type 1 diabetes estimates in children and adolescents | |
|---|---|
| People with type 1 diabetes (all age groups) | - |
| People with type 1 diabetes (0-19 y) | - |
| Demographics | |
|---|---|
| Total adult population (20-79 y), in 1,000s | 1,219,457.0 |
| Population of children and adolescents (0-19 y) | - |
